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Background: The prevalence of obesity in adults with intellectual disabilities has consistently been reported to be
higher than the general population. Despite the negative impact of obesity on health, there is little evidence of the
effectiveness of weight management interventions for adults with intellectual disabilities and obesity. Preliminary
results from a single-stranded feasibility study of a multi-component weight management intervention specifically
designed for adults with intellectual disabilities and obesity (TAKE 5) and that satisfied clinical recommendations
reported that it was acceptable to adults with intellectual disabilities and their carers. This study aims to determine
the feasibility of a full-scale clinical trial of TAKE 5.
Methods: This study will follow a pilot randomised trial design. Sixty-six obese participants (body mass index
(BMI) ≥30 kg/m2) will be randomly allocated to the TAKE 5 multi-component weight management intervention
or a health education ‘active’ control intervention (Waist Winners Too (WWToo)). Both interventions will be delivered
over a 12-month period. Participants’ anthropometric measures (body weight, BMI, waist circumference, percentage
body fat); indicators of activity (levels of physical activity and sedentary behaviour) and well-being will be measured
at three time points: baseline, 6 and 12 months. The researcher collecting outcome measures will be blind to
study group allocation.
Conclusions: The data from this study will generate pilot data on the acceptability of randomisation, attrition
rates and the estimates of patient-centred outcomes of TAKE 5, which will help inform future research and
the development of a full-scale randomised clinical trial.
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Intellectual disability is defined as the ‘disability charac-
terised by significant limitations both in intellectual func-
tioning and in adaptive behaviour, which covers everyday
social and practical skills. The disability originates before
the age of 18 years [1]’. Individuals with intellectual dis-
abilities have consistently been reported to have higher
rates of obesity than the general population [2-6]. Obesity,
defined as a body mass index (BMI) of 30 kg/m2 or
greater, is known to have a negative impact on health,
associated with chronic diseases such as cardiovascu-
lar disease [7], some cancers [8] and type II diabetes [9].
Being overweight or obese has shown to further exacer-
bate the health needs and already reduced life expectancy
of adults with intellectual disabilities [10]. Despite the
negative impact of obesity on health, there is a limited
evidence base to inform the management of obesity in this
population [11].
Clinical guidance on the management of obesity advo-
cates that adults who are overweight or obese should
aim for a clinically important, sustainable weight loss of
5%–10% of initial body weight [12,13]. To achieve this
multi-component weight management, interventions are
recommended which include as follows:
1. Dietary changes to create an energy deficit diet
(EDD) of 2,510 kilojoules (kJ)/day (600 kilocalories
(kcal/day).
2. Support to increase physical activity levels and
decrease inactivity.
3. Incorporation of behaviour change strategies to
facilitate dietary and activity changes.
4. A weight maintenance phase encouraging sustained
behaviour changes in healthy eating, increased
physical activity and reduced sedentary behaviour.
5. A minimum 12-month study period (including the
intervention and follow up) to examine the efficacy
of the intervention.
Multi-component interventions have been used in the
general population to successfully support individuals to
lose a clinically important weight [14]. However, there
are no published randomised controlled trials of weight
management interventions meeting clinical recommen-
dations in adults with intellectual disabilities.
Prior to this study, a single-stranded feasibility study was
carried out to examine the efficacy of TAKE 5; a multi-
component weight management intervention specifically
designed for adults with intellectual disabilities and obes-
ity [15,16]. TAKE 5 was developed in collaboration with
National Health Service (NHS) Greater Glasgow & Clyde
Weight Management Service (GCWMS) [14] and mod-
elled on their multi-component intervention, which incor-
porates diet and activity advice underpinned by behaviourchange approaches and based on clinical guidelines
[12,13]. Full results from the TAKE 5 feasibility study
have been published previously [15,16]. The feasibility
study found that TAKE 5 was acceptable to adults with in-
tellectual disabilities, and carers, and reported clinically
important reductions in body weight which were compar-
able to those achieved in adults with no reported intellec-
tual disability following the GCWMS multi-component
intervention [17]. Furthermore, clinically important re-
ductions in risk factors associated with chronic diseases,
such as waist circumference and increased physical activ-
ity levels, were also observed [15,16,18].
This study will add to the limited evidence base of con-
trolled trials which have examined the efficacy of weight
management interventions for adults with intellectual
disabilities by piloting an intervention meeting current
UK clinical recommendations on weight management.
This study will compare the effects of a multi-component
weight management intervention, TAKE 5 with a health
education control intervention which does not include
quantitative dietary advice to generate an individualised
energy deficit, Waist Winners Too (WWToo). The design
and rationale of the study with detail on the components
of both interventions will be reported in this protocol.
Aim
The overall aim of this pilot randomised trial is to exam-
ine the feasibility of a full-scale clinical trial of the TAKE 5
multi-component weight management intervention in
comparison with a health education control intervention.
The key research questions to determine the feasibility
of a full-scale randomised clinical trial are the following:
1. Can adults with intellectual disabilities and obesity
be recruited to a randomised study of the TAKE 5
intervention versus a health education control
intervention?
2. What attrition rates are observed at 6 and
12 months post-randomisation?
3. Are the patient centred outcome measures
acceptable to the participants and can they be
measured reliably to detect clinically important
changes?
4. What are the sample size requirements for a full-scale
clinical trial powered at 90% to determine a clinically
important difference in body weight?
Methods
The study will be conducted in accordance with the eth-
ical principles of the Declaration of Helsinki and consist-
ent with the principles of Good Clinical Practice. Ethical
approval has been received from the Scotland A Research
Ethics committee. In accordance with the Adults with
Incapacity (Scotland) Act 2000, a detailed protocol of
Harris et al. Pilot and Feasibility Studies 2015, 1:5 Page 3 of 12
http://www.pilotfeasibilitystudies.com/content/1/1/5consent was implemented. This included seeking con-
sent from individuals with intellectual disabilities with
the capacity to provide informed consent and seeking
consent from the nearest relative or welfare guardian
in circumstances where the individual was unable to
provide informed consent. Written informed consent
was obtained from all participants or nearest relative
or welfare guardian. Participants will have the right to
withdraw from the study at any time and to decline
to take part in any particular aspect or measure. This
will be explained to them whilst seeking consent and
their on-going consent will be checked and assessed
throughout the intervention.
Design
This study is a single-centre, single-blind pilot rando-
mised trial. It consists of two active intervention arms:
TAKE 5 multi-component weight management interven-
tion versus treatment as usual (TAU), health educa-
tional intervention, WWToo. TAU in most areas in the
UK for adults with intellectual disabilities and obesity
is inconsistent—ranging from no intervention to the
WWToo health education approach. An ‘active’ control
intervention is preferred to the traditional non-intervention
control group as due to the health risks associated with
obesity [19,20]; the research group believe it to be unethical
to offer participants to be randomised to the control group
with no intervention, for a 12-month period. Sixty-six par-
ticipants will be randomised to the study (33 to each treat-
ment arm) for a 12-month period; a 6-month weight loss
period (comprising of 9–12 sessions designed to take place
between two and three weekly intervals) followed by a 6-
month weight maintenance period (comprising of six ses-
sions taking place once a month). If the participants have
not lost a clinically relevant weight loss of 5% of initial
body weight at the end of the weight loss period, they will
be advised to continue on the weight loss plan for a
further 3 months, followed by a condensed 3-month
weight maintenance period, mirroring the procedures
conducted by the GCWMS and allowing a 12-month
‘intervention period’ for all participants. The study design
is illustrated in Figure 1.
Study population
Participants will be invited to take part in the study if
they meet the eligibility criteria presented in Table 1.
Recruitment
One aim of the proposed study is to examine recruitment
and retention to a randomised trial design and inform
recruitment strategies that could be used in the develop-
ment of a full-scale, multi-centre trial. Therefore, this
pilot randomised trial will use a multi-point recruitment
strategy, involving primary health care services, specialistintellectual disability services, relevant voluntary organisa-
tions and care provider organisations. A record will be
kept of the numbers of potential participants, and individ-
uals consenting to participate in the study, identified from
each of the recruitment points.
The research team will visit staff working in these set-
tings to explain the study and ask if their organisation
would be willing to support recruitment to the study. For
those staff willing to support recruitment to the study, a
supply of study information packs will be provided, com-
prising information about the study including an invita-
tion for potential participants to participate. Staff will be
invited to distribute these packs to service users who they
think would fulfil the study inclusion criteria and poten-
tially be willing to take part. Potential participants, who
reply to the invitation to the study by post using the self-
addressed envelope provided, will indicate whether they
would like to meet the researcher to find out more about
the study. The researcher (LH) will then contact partici-
pants to arrange a visit, at a convenient location to the
participant, to discuss the study. Individuals recruited to
the study may live together and/or be supported by the
same family or paid carers. These factors could make it
difficult to randomise people to the different treatment in-
terventions of the study and lead to some contamination
between treatments and clustering of outcomes. Cluster
randomisation, stratified by (and therefore analysed with
adjustment for) the number of individuals within a rando-
mised cluster, level of intellectual disabilities and presence
of Down Syndrome will account for the clustering of
outcomes and minimise imbalance between study groups.
Sample size
There is limited data from controlled trials of weight
management involving adults with intellectual disabilities
on which to base a sample size calculation. This study is
designed to estimate recruitment and retention rates for a
full-scale clinical trial; it is not powered to detect a differ-
ence between study groups. Sixty-six participants will be
recruited (33 to each treatment arm). This will provide
sufficient insight into recruitment and retention rates,
which will have a 95% confidence interval of no more
than ±10%. The sample size will allow for a possible
attrition rate of 20%. This study also aims to determine
likely variance of study outcomes in order to power a lar-
ger randomised trial; if 50 participants provide outcome
data at 12 months, a 90% confidence interval for each
variance estimate will have a width of approximately 70%
of the estimate (i.e. −26% to +44%).
Procedure
Participant eligibility will be assessed by the researcher
based on the inclusion and exclusion criteria (Table 1) at
an initial screening visit. Participants will also be asked to
Recruitment Information 
packs provided
Visit 1 Screening visit and    
consent
Visit 2 Baseline data           
collection
Randomisation
TAKE 5 Weight 
management Intervention 
(quantitative dietary advice)
Phase 1: Weight Loss
(9-12 sessions occurring 
every 2-3 weeks)
Individualised energy
deficit diet
Physical activity
Behaviour change
Visit 3 Outcome             
measurements ( 6 months 
from baseline)
Visit 3 Outcome             
measurements ( 6 months 
from baseline)
Visit 4 Post-intervention   
outcome measurements      
( 12 months from baseline)
Visit 4 Post-intervention   
outcome measurements      
( 12 months from baseline)
Phase 1: Weight Loss
(9-12 sessions occurring 
every 2-3 weeks)
Healthy lifestyle
sessions
Phase 2: Weight 
Maintenance
(6 sessions occurring 
once a month)
Dietary change
Physical activity
Relapse prevention
Phase 2: Weight 
Maintenance
(6 sessions occurring 
once a month)
Reviewing lifestyle    
changes
Question & Answer: Eat 
well & physical activity              
Waist Winners Too             
Intervention
(non-quantitative advice)
Figure 1 Study flow chart.
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(PARQ) [21] in order to identify any potential contrain-
dications to increasing their physical activity levels. If
participants score positively, they will be advised to
consult their doctor about whether they should participate
in the study.
After obtaining informed consent, the researcher will
arrange a visit to collect baseline outcome measures.Participants’ level of intellectual disability will be assessed
with questions assessing an individual’s level of ability and
need for support in five key areas of functioning: eating
and drinking, intimate care, personal safety, communica-
tion and decision making. A total score (range 5–25) is
obtained by adding together the scores from the five
individual questions. This will be used to categorise the
level of intellectual disability as mild, moderate, severe or
Table 1 Participant eligibility, inclusion and exclusion criteria
Criteria
Inclusion
Intellectual disability Any level of intellectual disability
Age Adults ≥18 years old (there is no upper age limit, in keeping with the GCWMS and specialist intellectual
disability health services in NHS GGC)
Weight status BMI ≥30 kg/m2
Ambulatory Ability to walk (with or without a walking aid) for 10 min at a time based on self/carer report
Diet Not currently on a prescribed or restricted diet, e.g. for phenylketonuria or diabetes
Weight stability No intentional weight loss >3 kg over the previous 3 months
Exclusion
Genetic intellectual disability Participants with Prader Willi syndrome, Cohen syndrome or Bardet-Biedl syndrome as they require specific
support to lose weight
Research Currently taking part in any other research study
Medication Taking medication; either prescribed or over the counter, designed for weight loss
Pregnancy Individuals who are pregnant will be excluded from the study and anyone who conceived during the
study will be excluded.
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ies of intellectual disabilities were derived in a previous
study [22] and shown to have a good level of agreement
with a validated structured assessment of functioning and
ability level, the Vineland’s Adaptive Behaviour Scale [23].
Participants will then be randomised into the TAKE 5
intervention or WWToo intervention. The researcher will
telephone an interactive voice response system (IVRS),
hosted by the Robertson Centre for Biostatistics, University
of Glasgow. The researcher will register each participant in
the study, by giving the participants’ cluster number, the
number of individuals within the cluster, level of intellec-
tual disabilities and presence of Down Syndrome. After
registering each participant, the system will notify the
principal investigator of the allocation (TAKE 5 interven-
tion or WWToo intervention). During post randomisation,
participants will be contacted by the research dietitian de-
livering the interventions and arrangements will be made
for their first session. Intervention sessions will take place
in a participant’s own home or, if an individual prefers, in
out-patient facilities located in the local learning disabilities
team base, or other NHS Greater Glasgow & Clyde setting.
The researcher collecting the data will be blind to group
allocation. After the first 6 months of weight loss phase
and at 12 months, all outcome measures will be repeated.
These data will be used to determine whether any changes
in outcome measures have been maintained.
Interventions
Both interventions will be delivered by a research dietitian.
The session frequency (9–12 sessions in the weight loss
phase and six sessions in the weight maintenance phase)
is to allow appointments to be organised flexibly to maxi-
mise the consistent involvement of family and paid carers.Previous research has shown that the involvement of
family and paid carers contributes to the effectiveness
of weight management interventions for adults with
intellectual disabilities [24,25]. Each session will last
approximately 40–60 min duration. This is to allow some
flexibility in the session content, required to take account
of the individual needs and abilities of participants. For
example, some participants and carers may prefer to have
shorter sessions or have extra sessions to develop an under-
standing of the information. This study will use appropriate
methods and techniques for augmentative communication,
e.g. talking mats and pictorial explanations that aim to
enable participants to express their choices during the
intervention [26]. Accessible resources, appropriate to the
developmental levels of adults with intellectual disabilities
were developed during the TAKE 5 feasibility study and
will be used to support participants in both intervention
arms. Supporting resources are designed to be used
flexibly with adults with all levels of learning disabilities,
involving family and paid carers where appropriate.
TAKE 5
TAKE 5 is an individualised intervention involving family
or paid carers to support participants, where appropriate.
It was adapted specifically for use with adults with intel-
lectual disabilities in that it is designed to be delivered on
a one-to-one basis with support from carers in the indi-
vidual’s home environment instead of a group setting as in
the GCWMS intervention [13].
TAKE 5 intervention components
The main themes discussed at each session for weight loss
and weight maintenance are illustrated in Tables 2 and 3,
respectively. Each session will focus on a discussion point
Table 2 Intervention key themes underpinning weight loss sessions
Session TAKE 5 Waist Winners Too
1 Benefits of losing weight and motivation towards a healthy lifestyle Introduction to health and weight
2 Introduction to individualised energy deficit diet and the importance of physical activity Planning meals
3 Principles of healthy eating and improving physical activity levels Food labelling and fats
Introduction to physical activity diaries and pedometer
4 Healthy ways to cook, meal planning and shopping lists Food labelling salt and sugar
Emotions and overeating
5 Disadvantages of eating out and take-aways Shopping, budgeting, snacks,
eating out and take-aways
Using behaviour change to alter ‘bad habits’
6 Coping with cravings and evaluating knowledge of physical activity Alcohol and other drinks
7 Diet myths and introduction to new ways to motivate participation in physical activity Benefits of exercise
8 Relapse prevention Review
9 Evaluate success up to now What have we learned
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change techniques (Table 2).
Diet
Phase 1—weight loss
To achieve a healthy sustainable weight loss of 0.5–
1.0 kg per week, a daily EDD of 600 kcal is recom-
mended [11,12]. Each individual’s daily energy deficit
will be calculated based on the estimate of their total en-
ergy expenditure −2,510 kJ (600 kcal). Basal metabolic
rate (BMR) will be calculated with gender, age, height
and weight using the Mifflin St. Jeor equation [27]. Total
energy expenditure is estimated from BMR multiplied by
a physical activity level of 1.3 [28].
The EDD provides daily caloric intake from a specified
number of daily portions from the five food groups in
the Eatwell plate: starchy foods such as bread, rice, pota-
toes and pasta; meat/fish and alternatives; fruit and vege-
tables; milk and dairy products; foods high in sugar and
fat [29]. The EDD also gives specific advice on portion
sizes and alternatives to energy dense food stuffs.Table 3 TAKE 5 key themes underpinning weight
maintenance sessions
Session Theme
1 Weight maintenance and new individualised maintenance
dietary plan
2 Importance of being active and adopting regular eating
patterns
3 Regular self-monitoring of weight and food intakes
4 Overview of barriers to healthy eating and physical activity
5 Snacking, lapses, eating out/social activities
6 Healthy menu plan and review of principles of weight
maintenancePhase 2—weight maintenance
In the weight maintenance phase, dietary intake will
continue to be based on the principles of portions from
the five food groups from the Eatwell plate [29]. How-
ever, this will not incorporate a daily EDD approach to
include a deduction of 600 kcal. Instead, each individ-
ual’s energy requirements will be calculated to maintain
energy balance.
Physical activity
Phase 1—weight loss
Results from the single-stranded feasibility study of
TAKE 5 reported that individuals with intellectual dis-
abilities and obesity have very sedentary lifestyles and
have low levels of physical activity spending an average
of 13.1 (SD 16.2) min per day in moderate-to-vigorous-
intensity physical activity [15]. The majority of physical ac-
tivity recommendations advocate 30 min of moderate-to-
vigorous physical activity on most days of the week
[30,31]. This may be unrealistic and unattainable for some
individuals with intellectual disabilities. Therefore, con-
sensus guidelines on physical interventions for beginners
[32] will be adhered to, initially aiming to support partici-
pants to progressively increase regular participation in
physical activity and reduce time spent being sedentary.
In each session, physical activity goals will be negotiated
and set based on the individual’s current level of physical
activity, physical ability and individual’s expressed pref-
erence, with the overall aim to gradually work towards
current physical activity recommendations advocated for
all adults.
Participants will be encouraged to reduce the time spent
sedentary, i.e. watching TV, by accumulating bouts of
physical activity over the course of the day. Current activ-
ity across three types of physical activity will be reviewed
with each participant and carer:
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behaviour, e.g. housework and gardening
 Walking—based on baseline average steps per day,
individuals will be encouraged to set targets to
progressively increase walking behaviour and use
pedometers to monitor step counts
 Sport and exercise—information will be given to
each participant on local leisure facilities and
clubs with disability accessible sports and exercise
groups/classes.Phase 2—weight maintenance
The importance of physical activity will be highlighted in
the maintenance phase as it plays an important role
in sustaining any reductions in body weight [12,13].
Individuals will be encouraged to build on the levels
of physical activity they achieved in phase 1 and con-
tinue to aim to meet clinical recommendations.Behaviour change techniques
Phase 1—weight loss
It is recommended that behaviour change techniques are
incorporated into weight management interventions to
support and maintain changes in attitudes and behaviour
in relation to healthy lifestyle patterns such as healthy eat-
ing, increased physical activity and a decrease in sedentary
behaviour [12,13]. The techniques incorporated into the
TAKE 5 intervention are based on the recommendation of
clinical guidelines and will include self-monitoring, goal
setting, management of eating behaviours, relapse preven-
tion, stimulus control, cue avoidance, reinforcement and
social assertion [15,18]. There are recognised challenges
to supporting behaviour change in adults with intellectual
disabilities. Therefore, TAKE 5 uses support from family
or paid carers to provide encouragement and motivation
for behaviour change and the behavioural methods above
flexibly in keeping with the needs and ability of levels of
participants [33].
Goal setting and dietary self-monitoring are key as-
pects of behaviour change [13]. Short-term goals incorp-
orating dietary change and physical activity will be set by
participants at the end of each session and reviewed sub-
sequently. Participants and carers will be provided with
daily diaries to facilitate monitoring of dietary intakes
and level of participation in physical activity. These will
be reviewed at each session and used to monitor pro-
gress towards goals, identify potential barriers to change
and discuss means to achieve goals. This information is
used as part of the intervention and will not be used as a
source of data for formal statistical analyses. When an
individual’s level of abilities allows additional behavioural
change, techniques will be included within the TAKE 5
intervention, such as problem solving and assertiveness.Phase 2—weight maintenance
To maintain a healthy body weight, behavioural strat-
egies used in the weight loss phase will continue to be
used flexibly. Specific approaches, such as problem solv-
ing and lapse and relapse prevention, are particularly
relevant to discuss and use during maintenance sessions.
Participants will be encouraged with support from carers
where appropriate to maintain the healthy lifestyle habits
from phase 1. Furthermore, they will be encouraged to
regularly self-monitor their body weight, food intake and
habitual physical activity. Goal setting will be used at the
end of each session (Table 3).
Control intervention (WWToo)
WWToo is a health education intervention developed by
a partnership group consisting of NHS dietitians, intel-
lectual disability nurses, health improvement specialists
and representatives from Glasgow Life, responsible for de-
livering community leisure facilities. WWToo was adapted
from a mainstream Waistwinners programme into an
accessible format for adults with intellectual disabilities.
The Waistwinners programme aims to increase knowledge
and skills to improve behaviour related lifestyle habits
such as healthy eating, weight management and physical
activity. The programme is a group-based intervention de-
livered over eight weekly sessions.
For the purpose of this research study, the delivery of
the WWToo intervention has been modified to an inter-
vention delivered on a one-to-one basis. Participants in
this control intervention will receive the same number
of face-to face sessions as participants in the TAKE 5
intervention. To retain participants to the study for the
same duration as TAKE 5, a weight maintenance phase
to WWToo was developed.
WWToo intervention components
Phase 1—weight loss
Diet Dietary change will be based on non-quantitative
advice based on the food groups from the Eatwell plate
[29]. Participants will not be given quantitative dietary ad-
vice but will be provided with knowledge about healthy
and unhealthy food groups to assist them to make an in-
formed decision on optimal food choice.
Physical activity
The physical activity component will follow the same
guidelines set out for the participants in the TAKE 5 inter-
vention. However, participants will not be encouraged to
self-monitor or increase their daily step counts using a
pedometer.
Behaviour change techniques
The behaviour change technique goal setting and self-
monitoring will be incorporated into the intervention
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ity. Participants will be invited to set a general dietary or
a physical activity goal for each session and to self-
monitor their food intake and physical activity.
Phase 2—weight maintenance
At each session, the dietitian will weigh the participant
and discuss their weight in the context of sustaining any
weight change. The opportunity for participants or
carers to ask any questions relevant to diet and physical
activity will be available at every session.
Outcome measures
A researcher (LH) who is blind to study group allocation
is responsible for collecting all outcome measures.
Demographic, health questionnaires and all other out-
come measures will be completed at baseline, at
6 months and at 12 months.
Primary outcome
The primary outcome measure will be the mean differ-
ence in body weight (kilograms (kg)) at 12 months from
baseline between the two treatment groups.
Secondary outcome
Secondary outcomes include weight loss of 5% or more
of initial body weight, change in BMI, waist circumfer-
ence and percentage body fat. Mean percentage time per
day spent engaged in moderate-vigorous intensity phys-
ical activity, light intensity physical activity and engage-
ment in sedentary behaviour.
Anthropometric outcomes
Participants will be invited to have their weight, height,
waist circumference and triceps skinfold thickness mea-
sured. Measurements will be made with the participant
wearing light clothes without shoes. All measurements will
be made in duplicate and the final value calculated as the
mean of the two measurements. Weight in kilograms will
be measured to the nearest 100 grams (g), using SECA877
scales (SE approval class III; SEA Germany). Height in
metres (m) will be measured to the nearest 1 mm using
the SECA Leicester stadiometer (SECA, Germany). The
height (m) and weight (kg) will be used to calculate BMI
using the formula BMI =weight/height (kg/m2).
Waist circumference will be measured to the nearest
0.5 cm at the midpoint between the iliac crest and the
lowest rib, in full expiration whilst the participant is
standing [34].
Due to the invasive nature of skinfold measurements
and the issue of level of compliance of adults with intel-
lectual disabilities, percentage body fat will be calculated
using only the triceps skinfold thickness (mm) measured
to the nearest 1 mm, waist circumference (cm) and age(years) of the participant. Separate regression equations
for male and female participants, developed by Lean
et al. [35] will be used to predict body density and per-
centage body fat.Physical activity outcome
To objectively measure physical activity, all participants
will be invited to wear accelerometers for 7 days on
three occasions, at baseline, 6 and 12 months. Acceler-
ometers have been used in studies involving adults with
intellectual disabilities and shown to be well utilised by
this group and to be a reliable and effective measure of
levels of physical activity [36,37].
Actigraph GT3X+ accelerometers (Manufacturing
Technology Inc., Florida) will be worn at the hip, at-
tached to a belt worn round the waist. Participants will
be invited to wear the actigraph GT3X+ over a 7-day
period. Instructions will be given to wear the actigraph
during all waking hours, except when showering, bathing
or swimming.
In keeping with guidelines on the validity of acceler-
ometer data, the minimum data requirement will be set
at 6 h of data, on at least 3 days from seven [38]. If this
requirement is not met, the accelerometer data will be
discarded and not be included in the analysis. The num-
ber of participants who fail to record sufficient records
of physical activity will be recorded. The accelerometers
will be set to record activity over 15-s intervals (epochs),
with activity counts of four consecutive epochs summed
to give activity counts per minute (cpm). Based on rec-
ommendations from previous studies [39], four categor-
ies of activity intensity will be defined:
 Sedentary behaviour 0–499 cpm.
 Light intensity activity 500–1,951 cpm.
 Moderate intensity activity 1,952–5,724 cpm.
 Vigorous intensity activity greater than 5,725 cpm.
The accelerometer data will then be used to calculate
the mean time (minutes) and the percentage time per day,
spent in each level of activity.
In addition, physical activity levels will also be measured
subjectively by administering the International Physical
Activity Questionnaire-Short (IPAQ-S). This will provide
information about the types of physical activity they par-
ticipated in.Health-related quality of life
To allow comparison with weight loss studies that do not
include adults with intellectual disabilities as participants,
the EQ-5D [40] will be used to measure health-related
quality of life. The EQ-5D has been shown to be reliable,
valid and sensitive to change in adults with obesity [41].
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difficult for adults with intellectual disabilities because of
the levels of communication and abstraction required.
The EQ-5D has been used as a proxy-measure of health-
related quality of life in studies involving adults with cog-
nitive impairments due to dementia [42,43] and stroke
[44]. In this study, carers will be asked to complete the
EQ-5D as a rating of the carer views of the five domains
in the EQ-5D, rather than as proxy-rating. Individuals
with mild intellectual disabilities will also be asked to
complete the EQ-5D and the level of agreement with carer
ratings examined. The wording from the youth version of
the EQ-5D will be used as it is aimed at young people
aged 7 years and older and is appropriate to the of verbal
comprehension of adults with mild/moderate intellectual
disabilities.
Process measures
An in-depth process evaluation of the interventions will
be conducted as a separate study on completion of the
study. Process measures will be collected as part of the
treatment protocol, as the research dietitian will also
complete written clinical notes at the end of each inter-
vention session, noting the success of components of the
interventions, and ways they adapted the approach (in ac-
cordance with the manual) to individual need and circum-
stances. The research dietitian will also collect routine
data on the number of sessions attended, participants’
body weight and information about the participants’ diet-
ary habits, physical activity and their success in using the
behaviour change techniques. Analysis of process evalu-
ation data will provide insight into multiple aspects of the
interventions and will capture experiences gained with de-
livering the interventions and the fidelity of the interven-
tions which will be used to help inform the development
of a full-scale clinical trial.
Data analysis
The main analysis of the pilot study will include de-
scriptive statistics of feasibility outcomes, including re-
cruitment rates and the acceptability of randomisation
(recorded from attrition rates). This analysis will help in-
form the development of a full-scale trial. Additional ana-
lysis of patient-centred outcomes will be carried out
according to a detailed pre-specified statistical analysis
plan. The primary efficacy analysis, change in body weight
at the end of the intervention period (≈12 months) from
baseline will use a linear regression (random effects)
model to take into account clustering and will be ad-
justed for randomised group, baseline weight and variables
used in the minimisation algorithm (level of intellectual
disabilities and presence of Down Syndrome). Similar lin-
ear regression models will be fitted for each continuous
secondary outcome measure. A logistic regression modelwill be fitted for the categorical outcome, weight loss of
5% or more of initial body weight taking account of clus-
tering and baseline adjustments listed above. Further ana-
lyses may assess the effects of baseline characteristics on
outcomes and investigate the evidence for interactions
with treatment effects using regression models.
Analyses will be conducted according to the intention
to treat (ITT) principle. Per-protocol analyses, including
only those participants who engaged with the programme,
will also be used to test the sensitivity of the ITT results.
Analyses will initially be performed using only those indi-
viduals for whom outcome data are available. Participants,
who are lost to follow-up, will be assessed to see if they
were different at baseline to those included in these ana-
lyses. As this is a pilot trial, the level of missing data will
be recorded, but no value imputation for outcome vari-
ables will be conducted.
Discussion
The increase prevalence of obesity and health inequal-
ities in adults with intellectual disabilities is further ac-
centuated by the limited access to evidence-based health
care in meeting the equality legislation and addressing
the health needs of this population group [45]. The need
for research on the management of obesity for adults
with intellectual disabilities has been emphasised as a
priority for research and an important step towards ad-
dressing this issue [12,13].
This pilot study will examine the feasibility of conduct-
ing a full-scale trial. The trial will help provide valuable
insight into the feasibility of key issues such as the ac-
ceptability of randomisation and the fidelity of the inter-
vention delivery.
Both arms of this trial are active interventions designed
to support adults to make healthier lifestyle choices, with
particularly focussed on supporting weight loss. This study
will compare the two dietary strategies, an individualised
EDD with quantitative dietary advice against a health edu-
cation approach without quantitative dietary advice. Both
interventions include support to increase physical activity
and incorporate behaviour change techniques. Thus, com-
paring the two interventions will allow the identification
of the essential and any superfluous components of the
intervention which will be used to inform the optimal
management approach to take forward in designing a full-
scale clinical trial to address the obesity epidemic in adults
with intellectual disabilities.
This study will make important contributions to the
available evidence in this field, by piloting an intervention
that fully satisfies UK clinical obesity guidelines on weight
management. In a recent review of weight management
interventions for adults with intellectual disabilities and
obesity, it was reported that there are relatively few pub-
lished studies and that the evidence available is subject to
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samples sizes with inadequate statistical power, and with
only a few studies implementing a randomised controlled
design [11]. None of the interventions met current recom-
mendations from UK clinical guidelines on the use of
multi-component interventions with an EDD for weight
loss [12,13]. Studies instead include combinations of a
component relevant to supporting individuals to increase
levels of physical activity, a dietary advice/health education
components or a component with a focus on behavioural
change. Furthermore, only a few studies were able to dem-
onstrate a clinically significant weight loss of 5%–10% of
initial body weight and met the recommended minimum
follow-up period of 12 months to examine the effective-
ness of a weight loss intervention.
Current guidelines on weight management interven-
tions recommend weight maintenance as an integral
component, illustrating that individuals who have lost a
clinically significant weight loss and are able to maintain
this weight have made substantial lifestyle changes that
will prevent future weight gain or health risks [12,13].
However, research for weight management in the general
population and adults with intellectual disabilities has
mainly focused on the development and evaluation of
weight loss strategies and has not examined extensively
the effectiveness of weight maintenance interventions
that immediately follow a weight loss phase [46]. Only
four studies involving participants with intellectual disabil-
ities offered a structured weight loss maintenance inter-
vention [24,25,47,48]. Of these, only one study, reported
the long-term effects of a 6-month weight maintenance
intervention [45], illustrating that after 6 months, most
adults with intellectual disabilities were able to sustain
the clinically significant weight lost in phase 1 or con-
tinue further to lose weight. This study will therefore add
to the evidence base by piloting a structured weight main-
tenance phase.
The controlled design is a key strength of this study, as it
is considered the optimal design to evaluate complex
interventions [49] and will add to the limited evidence of
controlled studies of weight management interventions of
adults with intellectual disabilities and obesity. There is lim-
ited evidence on which to base a best alternative control
intervention. An ‘active’ control intervention is selected for
this study over a non-intervention control; as in addition
to the ethical issues discussed previously, the research
group believes that this design would threaten the validity
of the study by not taking into consideration the specific
treatment effects of the intervention. In addition, it is be-
lieved that offering participants no intervention would
have a negative effect on study recruitment and retention
of participants. Receiving information on the importance
of weight management may influence participants receiv-
ing a non-intervention control to change their behaviourand seek out other resources available in order to make
healthier lifestyle choices. This could potentially cause
individuals to drop out from the study and/or make it dif-
ficult to follow individuals up when offering them no
intervention. The findings of this study will provide clear
direction on this key issue and guide future experimental
designs.
It is recognised that specific challenges are likely to arise
when conducting research with adults with intellectual
disabilities due to their cognitive and communication
needs. In particular, it is noted that recruitment of adults
with intellectual disabilities to research studies is challen-
ging and is evident from the small sample sizes reported
in previous research [11]. A review by Cleaver et al. [50]
reported that ethical procedures which are consistent with
this study such as the inability to contact potential partici-
pants directly and the procedures of taking consent may
lead to poor participation in studies involving adults with
intellectual disabilities. This study will assess the feasibility
of recruiting and retaining adults with intellectual dis-
abilities to a randomised design of a weight management
intervention using a multi-point recruitment strategy which
will collect information from recruitment sites such as or-
ganisations and services for adults with intellectual dis-
abilities. This will be used to identify potential barriers
and facilitators to recruitment which will help inform
other controlled trials of weight management interven-
tions and also be influential in informing the development
a full-scale multi-centre clinical trial.
Conclusion
There is limited access to evidence-based health care for
adults with intellectual disabilities. Currently, no pub-
lished controlled studies of weight management interven-
tions for adults with intellectual disabilities meet clinical
obesity recommendations. This pilot randomised trial will
examine the acceptability of randomisation and attrition
rates and provide pilot data on the estimates of patient-
centred outcomes of TAKE 5 compared to the health
education control intervention. If this study design is
acceptable to adults with intellectual disabilities and shows
a significant effect on outcome measures, this protocol
can serve as a framework or model on which development
of a full-scale clinical trial can be based.
Trial status
Recruitment commenced in February 2014 and is pro-
jected to be complete by November 2014.Abbreviations
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